Veeva Systems EBITDA Margin 2012-2025 | VEEV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Veeva Systems (VEEV) over the last 10 years. The current EBITDA margin for Veeva Systems as of January 31, 2025 is .
| Veeva Systems EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-01-31 | $2.75B | $0.72B | 26.26% |
| 2024-10-31 | $2.66B | $0.67B | 25.04% |
| 2024-07-31 | $2.57B | $0.61B | 23.62% |
| 2024-04-30 | $2.49B | $0.54B | 21.86% |
| 2024-01-31 | $2.36B | $0.45B | 19.20% |
| 2023-10-31 | $2.30B | $0.43B | 18.77% |
| 2023-07-31 | $2.23B | $0.43B | 19.32% |
| 2023-04-30 | $2.18B | $0.44B | 20.05% |
| 2023-01-31 | $2.15B | $0.51B | 23.54% |
| 2022-10-31 | $2.08B | $0.52B | 25.19% |
| 2022-07-31 | $2.00B | $0.54B | 26.95% |
| 2022-04-30 | $1.92B | $0.57B | 29.40% |
| 2022-01-31 | $1.85B | $0.57B | 30.58% |
| 2021-10-31 | $1.76B | $0.54B | 30.80% |
| 2021-07-31 | $1.67B | $0.51B | 30.63% |
| 2021-04-30 | $1.56B | $0.47B | 30.26% |
| 2021-01-31 | $1.47B | $0.43B | 29.33% |
| 2020-10-31 | $1.38B | $0.39B | 28.39% |
| 2020-07-31 | $1.28B | $0.37B | 28.50% |
| 2020-04-30 | $1.20B | $0.34B | 28.74% |
| 2020-01-31 | $1.11B | $0.32B | 29.23% |
| 2019-10-31 | $1.03B | $0.32B | 31.12% |
| 2019-07-31 | $0.97B | $0.30B | 30.96% |
| 2019-04-30 | $0.91B | $0.28B | 30.70% |
| 2019-01-31 | $0.86B | $0.25B | 29.32% |
| 2018-10-31 | $0.82B | $0.23B | 28.15% |
| 2018-07-31 | $0.77B | $0.21B | 27.44% |
| 2018-04-30 | $0.73B | $0.20B | 26.96% |
| 2018-01-31 | $0.69B | $0.19B | 27.64% |
| 2017-10-31 | $0.66B | $0.21B | 31.27% |
| 2017-07-31 | $0.63B | $0.19B | 30.89% |
| 2017-04-30 | $0.59B | $0.18B | 29.78% |
| 2017-01-31 | $0.55B | $0.15B | 27.40% |
| 2016-10-31 | $0.51B | $0.11B | 21.06% |
| 2016-07-31 | $0.47B | $0.09B | 19.49% |
| 2016-04-30 | $0.44B | $0.09B | 20.05% |
| 2016-01-31 | $0.41B | $0.09B | 21.76% |
| 2015-10-31 | $0.38B | $0.09B | 24.35% |
| 2015-07-31 | $0.36B | $0.09B | 25.63% |
| 2015-04-30 | $0.34B | $0.09B | 25.52% |
| 2015-01-31 | $0.31B | $0.08B | 24.52% |
| 2014-10-31 | $0.29B | $0.07B | 22.76% |
| 2014-07-31 | $0.26B | $0.06B | 21.07% |
| 2014-04-30 | $0.24B | $0.05B | 20.00% |
| 2014-01-31 | $0.21B | $0.04B | 19.91% |
| 2013-07-31 | $0.13B | $0.03B | 21.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $39.281B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $12.358B | 128.40 |
| Tempus AI (TEM) | United States | $10.796B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 72.09 |
| IRhythm Technologies (IRTC) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $3.055B | 208.83 |
| Enovis (ENOV) | United States | $2.089B | 11.65 |
| Clover Health Investments (CLOV) | United States | $1.773B | 0.00 |
| Schrodinger (SDGR) | United States | $1.765B | 0.00 |
| Phreesia (PHR) | United States | $1.531B | 0.00 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| Omnicell (OMCL) | United States | $1.286B | 22.69 |
| 10x Genomics (TXG) | United States | $1.161B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.515B | 154.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.441B | 0.00 |
| TruBridge (TBRG) | United States | $0.395B | 875.67 |
| Claritev (CTEV) | United States | $0.353B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.315B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.151B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |